adizie case series: difficult-to-treat gca in 9 patients
DESCRIPTION
Leflunomide in GCA. Adizie Case series: Difficult-to-treat GCA in 9 patients Partial/complete response achieved in 21/23 Well tolerated, decrease in inflammatory markers, decreased steroid doses Diamantopoulos Case series: refractory GCA in 11 patients - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/1.jpg)
![Page 2: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/2.jpg)
![Page 3: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/3.jpg)
![Page 4: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/4.jpg)
![Page 5: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/5.jpg)
![Page 6: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/6.jpg)
![Page 7: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/7.jpg)
![Page 8: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/8.jpg)
![Page 9: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/9.jpg)
![Page 10: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/10.jpg)
![Page 11: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/11.jpg)
![Page 12: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/12.jpg)
![Page 13: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/13.jpg)
![Page 14: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/14.jpg)
![Page 15: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/15.jpg)
![Page 16: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/16.jpg)
![Page 17: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/17.jpg)
![Page 18: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/18.jpg)
![Page 19: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/19.jpg)
![Page 20: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/20.jpg)
![Page 21: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/21.jpg)
Adizie• Case series: Difficult-to-treat GCA in 9 patients• Partial/complete response achieved in 21/23• Well tolerated, decrease in inflammatory markers,
decreased steroid dosesDiamantopoulos
• Case series: refractory GCA in 11 patients• 12.4 mg/dL (CI 95% 0.7-25.5, P = .06) reduction
in CRP • 6.6 mg (CI 95% 2.8-10.3, P < .01) reduction in
prednisolone dose
Adizie T, et al. Int J Clin Pract. 2012;66:906-909.[7] Diamantopoulos AP, et al. Biomed Res Int. 2013;2013:120638.[14]
Leflunomide in GCA
![Page 22: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/22.jpg)
![Page 23: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/23.jpg)
![Page 24: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/24.jpg)
![Page 25: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/25.jpg)
![Page 26: Adizie Case series: Difficult-to-treat GCA in 9 patients](https://reader035.vdocuments.site/reader035/viewer/2022062810/56815ab5550346895dc8694b/html5/thumbnails/26.jpg)